Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype

被引:172
作者
Beider, Katia [1 ,2 ]
Bitner, Hanna [1 ,2 ]
Leiba, Merav [1 ,2 ]
Gutwein, Odit [1 ,2 ]
Koren-Michowitz, Maya [1 ,2 ]
Ostrovsky, Olga [1 ,2 ]
Abraham, Michal [4 ]
Wald, Hanna [4 ]
Galun, Eithan [3 ]
Peled, Amnon [3 ]
Nagler, Arnon [1 ,2 ]
机构
[1] Chaim Sheba Med Ctr, Guy Weinshtock Multiple Myeloma Fdn, Div Hematol, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Guy Weinshtock Multiple Myeloma Fdn, CBB, IL-52621 Tel Hashomer, Israel
[3] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel
[4] Biokine Therapeut Ltd, Ness Ziona, Israel
关键词
MM; M2; macrophages; CXCR4; BONE-MARROW; ANGIOGENESIS; PROGRESSION; DISEASE; TARGETS; CHEMOKINES; GROWTH; STEM; FACTOR-1-ALPHA; ENVIRONMENT;
D O I
10.18632/oncotarget.2207
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Multiple myeloma (MM) cells specifically attract peripheral-blood monocytes, while interaction of MM with bone marrow stromal cells (BMSCs) significantly increased monocyte recruitment (p<0.01). The CXCL12 chemokine, produced by both the MM and BMSCs, was found to be a critical regulator of monocyte migration. CXCL12 production was up-regulated under MM-BMSCs co-culture conditions, whereas blockage with anti-CXCR4 antibodies significantly abrogated monocyte recruitment toward a MM-derived conditioned medium (p<0.01). Furthermore, elevated levels of CXCL12 were detected in MM, but not in normal BM samples, whereas malignant MM cells often represented the source of increased CXCL12 in the BM. Blood-derived macrophages effectively supported MM cells proliferation and protected them from chemotherapy-induced apoptosis. Importantly, MM cells affected macrophage polarization, elevating the expression of M2-related scavenger receptor CD206 in macrophages and blocking LPS-induced TNF alpha secretion (a hallmark of M1 response). Of note, MM-educated macrophages suppressed T-cell proliferation and IFN. production in response to activation. Finally, increased numbers of CXCR4-expressing CD163+CD206+ macrophages were detected in the BM of MM patients (n =25) in comparison to MGUS (n =11) and normal specimens (n =8). Taken together, these results identify macrophages as important players in MM tumorogenicity, and recognize the CXCR4/CXCL12 axis as a critical regulator of MM-stroma interactions and microenvironment formation.
引用
收藏
页码:11283 / 11296
页数:14
相关论文
共 42 条
[1]
Chemokines in multiple myeloma [J].
Aggarwal, Rohit ;
Ghobrial, Irene A. ;
Roodman, G. David .
EXPERIMENTAL HEMATOLOGY, 2006, 34 (10) :1289-1295
[2]
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation [J].
Atanackovic, Djordje ;
Cao, Yanran ;
Luetkens, Tim ;
Panse, Jens ;
Faltz, Christiane ;
Arfsten, Julia ;
Bartels, Katrin ;
Wolschke, Christine ;
Eiermann, Thomas ;
Zander, Axel R. ;
Fehse, Boris ;
Bokemeyer, Carsten ;
Kroger, Nicolaus .
HAEMATOLOGICA, 2008, 93 (03) :423-430
[3]
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma [J].
Azab, Abdel Kareem ;
Azab, Feda ;
Blotta, Simona ;
Pitsillides, Costas M. ;
Thompson, Brian ;
Runnels, Judith M. ;
Roccaro, Aldo M. ;
Ngo, Hai T. ;
Melhem, Molly R. ;
Sacco, Antonio ;
Jia, Xiaoying ;
Anderson, Kenneth C. ;
Lin, Charles P. ;
Rollins, Barrett J. ;
Ghobrial, Irene M. .
BLOOD, 2009, 114 (03) :619-629
[4]
Multiple Myeloma Bone Marrow Niche [J].
Basak, Grzegorz Wladyslaw ;
Srivastava, Anand S. ;
Malhotra, Rakesh ;
Carrier, Ewa .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2009, 10 (03) :335-346
[5]
Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140 [J].
Beider, Katia ;
Ribakovsky, Elena ;
Abraham, Michal ;
Wald, Hanna ;
Weiss, Lola ;
Rosenberg, Evgenia ;
Galun, Eithan ;
Avigdor, Abraham ;
Eizenberg, Orly ;
Peled, Amnon ;
Nagler, Arnon .
CLINICAL CANCER RESEARCH, 2013, 19 (13) :3495-3507
[6]
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm [J].
Biswas, Subhra K. ;
Mantovani, Alberto .
NATURE IMMUNOLOGY, 2010, 11 (10) :889-896
[7]
Multiple myeloma-related deregulation of bone marrow-derived CD34+ hematopoietic stem and progenitor cells [J].
Bruns, Ingmar ;
Cadeddu, Ron-Patrick ;
Brueckmann, Ines ;
Froebel, Julia ;
Geyh, Stefanie ;
Buest, Sebastian ;
Fischer, Johannes C. ;
Roels, Frederik ;
Wilk, Christian Matthias ;
Schildberg, Frank A. ;
Huenerlituerkoglu, Ali-Nuri ;
Zilkens, Christoph ;
Jaeger, Marcus ;
Steidl, Ulrich ;
Zohren, Fabian ;
Fenk, Roland ;
Kobbe, Guido ;
Brors, Benedict ;
Czibere, Akos ;
Schroeder, Thomas ;
Trumpp, Andreas ;
Haas, Rainer .
BLOOD, 2012, 120 (13) :2620-2630
[8]
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients [J].
Cao, Yanran ;
Luetkens, Tim ;
Kobold, Sebastian ;
Hildebrandt, York ;
Gordic, Maja ;
Lajmi, Nesrine ;
Meyer, Sabrina ;
Bartels, Katrin ;
Zander, Axel R. ;
Bokemeyer, Carsten ;
Kroeger, Nicolaus ;
Atanackovic, Djordje .
EXPERIMENTAL HEMATOLOGY, 2010, 38 (10) :860-867
[9]
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche [J].
Chow, Andrew ;
Lucas, Daniel ;
Hidalgo, Andres ;
Mendez-Ferrer, Simon ;
Hashimoto, Daigo ;
Scheiermann, Christoph ;
Battista, Michela ;
Leboeuf, Marylene ;
Prophete, Colette ;
van Rooijen, Nico ;
Tanaka, Masato ;
Merad, Miriam ;
Frenette, Paul S. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (02) :261-271
[10]
Synopsis of a roundtable on validating novel therapeutics for multiple myeloma [J].
Dalton, William ;
Anderson, Kenneth C. .
CLINICAL CANCER RESEARCH, 2006, 12 (22) :6603-6610